These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25384359)

  • 1. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
    Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
    Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of an aggressive approach to resection of locally recurrent rectal cancer.
    Wells BJ; Stotland P; Ko MA; Al-Sukhni W; Wunder J; Ferguson P; Lipa J; Last L; Smith AJ; Swallow CJ
    Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
    Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
    Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
    Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-stage anterior high sacrectomy for locally recurrent rectal cancer.
    Fawaz K; Smith MJ; Moises C; Smith AJ; Yee AJ
    Spine (Phila Pa 1976); 2014 Mar; 39(5):443-52. PubMed ID: 24573075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
    Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
    Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
    Holman FA; Bosman SJ; Haddock MG; Gunderson LL; Kusters M; Nieuwenhuijzen GA; van den Berg H; Nelson H; Rutten HJ
    Eur J Surg Oncol; 2017 Jan; 43(1):107-117. PubMed ID: 27659000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after curative resection for locally recurrent rectal cancer.
    Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
    Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes after isolated local recurrence of rectal cancer and risk analysis affecting its resectability.
    Park YY; Lee J; Han YD; Cho MS; Hur H; Min BS; Lee KY; Oh ST; Kim NK
    J Surg Oncol; 2020 Dec; 122(7):1470-1480. PubMed ID: 32794188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.
    Dresen RC; Gosens MJ; Martijn H; Nieuwenhuijzen GA; Creemers GJ; Daniels-Gooszen AW; van den Brule AJ; van den Berg HA; Rutten HJ
    Ann Surg Oncol; 2008 Jul; 15(7):1937-47. PubMed ID: 18389321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
    Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
    Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.